Cancer During Pregnancy: Chemotherapy and Radiotherapy are Safe for Babies, Studies Show
Presentations at ESMO 2014 examine the impact of in-utero exposure to chemotherapy and radiotherapy; the safety of lymph node biopsy in pregnancy; and the outcomes of unplanned pregnancy during cancer treatment. Complete article on the website of ESMO.
Prof. dr. Frederic Amant was interviewed by ecancer at the 2013 ESGO Meeting in Liverpool about a follow-up study on children whose mothers received chemotherapy during pregnancy.
The Journal of Clinical Oncology paper "Prognosis of Women With Primary Breast Cancer
Diagnosed During Pregnancy: Results From an International Collaborative Study" has been reported in The Lancet Oncology.
Reuters Health reports on study by Frédéric Amant and his team in the Journal of Clinical Oncology. The study reports findings that survival among women diagnosed with breast cancer when pregnant was comparable to that for non-pregnant women of reproductive age treated for breast cancer.
On December 13, Princess Mathilde of Belgium visited the Cancer in Pregnancy research team at UZ Leuven. She spoke to researchers and caregivers, toured the laboratory and met with seven mothers who have been through cancer during pregnancy.
On September 16th, the Catholic University of Leuven, Dept. of Woman & Child, organized the Symposium 'Cancer during Pregnancy', framing in the Flemish League against Cancer Chair dedicated to the research project this year.
Download the calendar of presentation dates on the topic of Cancer in Pregnancy.
Prof. dr. Frédéric Amant of KU Leuven directs research into the treatment of cancer in pregnant women and the consequences of such treatment on foetal development. In her PhD dissertation on chemotherapy during pregnancy, Kristel Van Calsteren presents a number of new scientific discoveries.